Grants and Contributions:

Title:
Treating diabetes with beta cell targeted mRNA delivery
Agreement Number:
1002669
Agreement Value:
$25,000.00
Agreement Date:
Mar 16, 2023 - Sep 30, 2024
Description:
Advances exploratory research under the New Beginnings Initiative
Organization:
National Research Council Canada
Expected Results:

In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.

Location:
Montreal, Quebec, CA H2W 1R7
Reference Number:
172-2022-2023-Q4-1002669
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
107508194
Recipient Type:
Not-for-profit organization or charity
Recipient's Legal Name:
Montreal Clinical Research Institute (IRCM)
Federal Riding Name:
Laurier–Sainte-Marie
Federal Riding Number:
24039
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:

The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.

NAICS Code:
541710